From Broad GenAI Experiments to a Governed RFP Workflow
Moved broad enterprise AI experimentation into a private, source-grounded RFP workflow with defined acceptance criteria, evidence controls and accountable human review.
97% final acceptance
Selected work showing how high-stakes mandates were turned into clearer decisions, accountable execution and measurable operating evidence.
InteliGems Advisory helps boards, investors and executive teams determine whether they are facing an execution issue, a product issue or a weakening business thesis and carry that decision into operating change rather than leaving it as a recommendation.
Moved broad enterprise AI experimentation into a private, source-grounded RFP workflow with defined acceptance criteria, evidence controls and accountable human review.
Advisory work for orthopedic manufacturer board gate decisions to scale commitment. Prove buyer-specific business case economics, clinical workflow fit and sales interest under bundled payment risk.
Applied a custom case tagging framework for pinpointing evidence. 100K mixed records, deposition deadlines while keeping privilege, source traceability and legal counsel control. Curation cut first-pass from 42 days to 2.5 days.
Re-established governance, SDLC discipline, release control, and executive KPI visibility across troubled Medicaid programs in New Hampshire and Montana. Rationalized EPMO resources and delivery staffing to address chronic delays and execution risk. 2 state programs reset under formal governance and release discipline
Results:
Aligned account strategy, executive sponsorship, delivery dependencies and growth priorities around the customer’s operating requirements.
Results:
Legacy customizations and clinical workflow friction constrained growth for a real-world clinical evidence organization. Led a multi-workstream modernization; workflow, cloud data architecture, pharmacovigilance feeds and lower-cost EDC systems to free specialist capacity for new business.
Results:
Redirected capital, team capacity, product work and GTM from a commoditizing meeting-intelligence market into private, governed AI for control-sensitive enterprise work.
Results:
Standardized screening and evidence assembly while preserving controlled sources, escalation thresholds, traceability and specialist decision authority.
Results:
Applied an AI-assisted evidence workflow to verify source-linked hits, remove false positives, and classify recurring bias mechanisms. Seven bias mechanisms identified, work published.
Results:
A $1M+ license rested on ~$300K of emergency dept. avoidance value. Four pathways expanded the modeled case to $1M–$5M+ a year with a value model tool so buyer executives could test local assumptions. The results opened doors for deeper enterprise sales conversations.
Results:
Field research across five sites shifted the decision from digitizing every interaction to where digital change justified the interaction cost.
Results:
Commercialization under uncertainty: Military-tested IV platform, many plausible civilian markets, no clear beachhead. Compressed validation cycles to 30 days across 10 market segments and anchoring a $498M promising market. Validate which buyers will adopt, preserve capital for regulatory filings.
Results:
Structured buyer, use-case, persona, product-market-fit and sales-enablement decisions into a commercialization plan.
Results:
Led enterprise planning, delivery, execution and operating accountability across a $90M P&L and 1,100-person global team.
Results:
Built and led a 100+ employee healthcare technology company across mobile applications, SaaS products and professional services through exit.
Results:
When important decisions need operating experience, get principal-led support.
Principal-led advisory and operating leadership for executive teams facing consequential AI, governance, transformation, commercialization, and recovery mandates.
advisory@inteligems.io
